top of page
HeroGradient.png

Meet the team

The Remedy Plan team comprises seasoned drug discovery leaders, medicinal chemists, and biomedical experts with proven track records in drug development.

Our advisors, investors, and board of directors include accomplished biotech entrepreneurs with experience in bringing drugs to market.

Gradient-circle-blue_2400x1350.jpg

The Remedy Plan team comprises seasoned drug discovery leaders and biomedical experts with proven track records in drug development. Our advisors, investors, and board of directors include accomplished biotech entrepreneurs with experience in bringing drugs to market.

Meet the team

Gradient-circle-blue_2400x1350.jpg

Meet the team

The Remedy Plan team comprises seasoned drug discovery leaders, medicinal chemists, and biomedical experts with proven track records in drug development. Our advisors, investors, and board of directors include accomplished biotech entrepreneurs with experience in bringing drugs to market.

Leadership Team

Greg Crimmins, PhD

Cofounder & Chief Executive Officer

Dennise A. De Jesús-Díaz, PhD 

Cofounder & Chief Operating Officer 

Jotin Marango, MD, PhD

Chief Financial and Business Officer

Michael Schelle, PhD

Chief Scientific Officer

Board of Directors

Greg Crimmins, PhD
Frank McCormick, PhD, FRS, DSc 
Owen Hughes
Alex Manick
Christian Waage

Advisors

Saul H. Rosenberg, PhD
Drug development advisor - hematology
Jay S. Skyler, MD, MACP, FRCP
Research advisor – metabolism
Steve Sabus
Corporate advisor
Vahe Bedian, PhD
Research advisor – oncology
Tom Dubensky, PhD
Corporate advisor
Erika Pearce, PhD
Research advisor – oncology
Ed Pearce, PhD
Research advisor – metabolism
Russell Vance, PhD
Research advisor - immunology
Daniel Portnoy, PhD
Corporate advistor
Ronald Parchem, PhD
Research advisor - oncology
bottom of page